Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, announced progress in regulatory and deployment activities for its telehealth platform in Venezuela. The company is working with Venezuela's Ministerio del Poder Popular para la Salud, including the Servicio Autónomo de Contraloría Sanitaria (SACS), to obtain the required Permiso Sanitario de Funcionamiento para Plataforma Digital.
The platform, accessible at https://latamedai.org, is currently undergoing early-stage deployment, testing, and refinement. Catalyst Crew is evaluating system performance, user workflows, and operational capabilities as part of its initial launch. The telehealth platform is designed to support remote patient engagement, care coordination, and integration of AI-driven healthcare analytics tools.
Management anticipates completing the permitting process in the near term but offers no assurance on timing or outcome. The company believes this phase of deployment, testing, and regulatory alignment is an important step toward broader operational rollout across target markets.
Dr. Kevin Rodan Levy, CEO of Catalyst Crew Technologies, stated: “Our focus is on building a scalable telehealth platform that can operate effectively within real-world healthcare environments. We are currently advancing platform testing, refinement, and regulatory alignment as we continue to build the foundation for broader deployment across Latin America. We expect a full launch in short order and upon receiving all regulatory approvals.”
The company continues to develop its digital health and AI platform, including telehealth infrastructure and AI-driven healthcare analytics capabilities. Further information is available at https://catalystcrewai.com or in the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
Catalyst Crew Technologies is an AI-driven healthcare technology company focused on scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. The company is executing a strategic transition into AI-enabled healthcare, pursuing opportunities in telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms.
This press release contains forward-looking statements subject to risks and uncertainties. Actual results may differ materially due to factors including the company's ability to implement its business plan, secure financing, complete acquisitions, comply with regulatory requirements, and general market conditions. The company undertakes no obligation to update forward-looking statements except as required by law.
